Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.9 - $17.11 $179,310 - $237,829
13,900 Added 556.0%
16,400 $229,000
Q2 2024

Aug 14, 2024

BUY
$11.93 - $16.34 $4,772 - $6,536
400 Added 19.05%
2,500 $32,000
Q1 2024

May 15, 2024

SELL
$15.15 - $21.58 $80,295 - $114,373
-5,300 Reduced 71.62%
2,100 $34,000
Q4 2023

Feb 14, 2024

SELL
$15.75 - $21.38 $22,050 - $29,932
-1,400 Reduced 15.91%
7,400 $155,000
Q3 2023

Nov 14, 2023

SELL
$20.22 - $27.36 $792,624 - $1.07 Million
-39,200 Reduced 81.67%
8,800 $186,000
Q2 2023

Aug 14, 2023

SELL
$19.39 - $28.9 $42,658 - $63,580
-2,200 Reduced 4.38%
48,000 $1.3 Million
Q1 2023

May 15, 2023

BUY
$12.71 - $21.17 $531,278 - $884,906
41,800 Added 497.62%
50,200 $987,000
Q4 2022

Feb 14, 2023

BUY
$11.23 - $19.44 $94,332 - $163,296
8,400 New
8,400 $114,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $427M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.